gms | German Medical Science

64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

26. - 29. Mai 2013, Düsseldorf

Outcome of patients with cerebral metastases undergoing iMRI-guided tumor resection

Meeting Abstract

  • Christian Senft - Klinik für Neurochirugie, Klinikum der Goethe-Universität Frankfurt
  • Florian Gessler - Klinik für Neurochirugie, Klinikum der Goethe-Universität Frankfurt
  • Stephan Dützmann - Klinik für Neurochirugie, Klinikum der Goethe-Universität Frankfurt
  • Patrick Harter - Edinger Institut, Klinikum der Goethe-Universität Frankfurt
  • Kea Franz - Klinik für Neurochirugie, Klinikum der Goethe-Universität Frankfurt
  • Volker Seifert - Klinik für Neurochirugie, Klinikum der Goethe-Universität Frankfurt

Deutsche Gesellschaft für Neurochirurgie. 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Düsseldorf, 26.-29.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocMI.06.01

doi: 10.3205/13dgnc322, urn:nbn:de:0183-13dgnc3226

Veröffentlicht: 21. Mai 2013

© 2013 Senft et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: In contrast to glioma surgery, the value of radiologically complete resection and the use of surgical adjuncts to optimize the extent of resection are not well established for patients with cerebral metastases (CM). Our aim was to report on the outcome of patients undergoing intended complete resection of CM using intraoperative MRI guidance.

Method: Retrospective analysis of our prospectively collected database of patients undergoing resection of a histopathologically proven CM with the use of an intraoperative MRI.

Results: 18 patients were included in this analysis. The mean age was 65 years. Median follow-up was 16.7 months. All patients were in good clinical condition (EGOG 0 and 1) and harbored single CM. In three patients (16.7%), iMRI revealed residual contrast-enhancing tissue when tumor resection was thought to be complete. In all three cases, this tissue was resected and was found to be infiltrative tumor on histopathological assessment. In four patients, 5-ALA was also used, but only one of these tumors (25%) exhibited red fluorescence under blue light. Early postoperative MRI confirmed complete resection of contrast-enhancing tissue in all patients (100%). Kaplan Meier analysis rendered a median overall survival following CM resection of 22.6 months (95%-CI: 4.1–41.2).

Conclusions: CMs are not encapsulated, but infiltratively growing tumors. Therefore, intraoperative MRI as a surgical adjunct enhances completeness of tumor resection. Aggressive surgical treatment of single CMs appears to lead to a survival benefit.